Fredun Pharmaceuticals fundamental analysis

FREDUN

1499

100.70 (7.20%)
Last updated on 13 Jan, 2026 | 15:26 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Fredun Pharmaceuticals Fundamentals

P/E Ratio

38.02

P/B Ratio

3.16

Div. Yield

0.05

Sector P/E

69.86

Sector P/B

0.96

Sec. Div. Yield

0.57

Fredun Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 38.02, compared to the sector average of 69.86. Its P/B Ratio stands at 3.16, while the sector’s is 0.96. In terms of returns, the stock offers a Dividend Yield of 0.05%, which is than the sector’s 0.57%.

Fredun Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Good

On its scorecard, Fredun Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.